| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.45 | 7e-26 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.093 | 0.07 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.068 | 0.1 |